Medicare Enrolled

Dr. Arnaldo Negron, MD

Dermatology · Skillman, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
11 TAMARACK CIR, Skillman, NJ 08558
6092791339
In practice since 2006 (19 years)
NPI: 1659488138 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Negron from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Negron? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Negron

Dr. Arnaldo Negron is a dermatology specialist in Skillman, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Negron performed 258 Medicare services across 66 unique beneficiaries.

Between the years covered by Open Payments, Dr. Negron received a total of $20,428 from 34 pharmaceutical and/or device companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Negron is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 258 Medicare services $20,428 industry payments

Medicare Practice Summary

Medicare Utilization ↗
258
Medicare services
Bottom 25% in NJ for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
66
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 258 $96 $155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,428
Total received (2018-2024)
Avg $2,918/year across 7 years
Top 3% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
501
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,853 (43.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,313 (35.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,262 (20.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$578
2023
$415
2022
$330
2021
$239
2020
$383
2019
$1,559
2018
$16,923

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$166
Takeda Pharmaceuticals U.S.A., Inc.
$68
Axsome Therapeutics, Inc.
$67
Noven Therapeutics, LLC
$50
Otsuka America Pharmaceutical, Inc.
$49
Novo Nordisk Inc
$33
Corium, LLC
$33
Alkermes, Inc.
$32
ABBVIE INC.
$30
Lundbeck LLC
$19
Supernus Pharmaceuticals, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$8,159
Takeda Pharmaceuticals U.S.A., Inc.
$7,742
Allergan Inc.
$836
Lundbeck LLC
$542
Neuronetics, Inc.
$488
Vanda Pharmaceuticals Inc.
$274
Neos Therapeutics, LP
$266
Sunovion Pharmaceuticals Inc.
$245
ITI, Inc.
$227
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$166
Allergan, Inc.
$140
Teva Pharmaceuticals USA, Inc.
$125
Novo Nordisk Inc
$103
Avanir Pharmaceuticals, Inc.
$102
Corium, LLC
$90
Axsome Therapeutics, Inc.
$86
ABBVIE INC.
$82
Pernix Therapeutics Holdings, Inc.
$81
Ironshore Pharmaceuticals Inc.
$68
Shire North American Group Inc
$65
Janssen Pharmaceuticals, Inc
$64
Supernus Pharmaceuticals, Inc.
$56
ARBOR PHARMACEUTICALS, INC.
$52
Bausch Health US, LLC
$51
Noven Therapeutics, LLC
$50
Alkermes, Inc.
$47
Indivior Inc.
$46
JAZZ PHARMACEUTICALS INC.
$44
Neurocrine Biosciences, Inc.
$43
Merck Sharp & Dohme Corporation
$25
AbbVie Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$15
Jazz Pharmaceuticals Inc.
$14
Adlon Therapeutics L.P.
$13
Top 3 companies account for 81.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Evekeo · Fanapt · HETLIOZ · INGREZZA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · REXULTI · SILENOR · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Saxenda · TREXIMET · TRINTELLIX · Trintellix · VIIBRYD · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Wegovy · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for dermatology in NJ.

Looking for a dermatology specialist in Skillman?
Compare dermatologists in the Skillman area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
57
Per 100K population
16.5
County median income
$135,960
Nearest hospital
HACKENSACK MERIDIAN HEALTH CARRIER CLINIC
3.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Negron is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Negron experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Negron performed 258 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Negron receive payments from pharmaceutical companies?
Yes. Dr. Negron received a total of $20,428 from 34 companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Negron's costs compare to other dermatologists in Skillman?
Dr. Negron's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Negron) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Skillman
Browse dermatologists in Skillman ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →